Pena Shokeir syndrome, type 1

Search Trials
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)
Status:
Recruiting
Last Changed:
Apr 26, 2022
First Changed:
Sep 18, 2020
Disease(s):
Essential Fatty Acid Deficiency (EFAD)
Intervention(s):
ClinolipidIntralipid
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion
Status:
Terminated
Last Changed:
Jul 21, 2021
First Changed:
Jun 22, 2015
Disease(s):
Essential Fatty Acid Deficiency (EFAD)
Intervention(s):
ClinolipidIntralipid
Canola Oil Multicentre Intervention Trial
Status:
Completed
Last Changed:
Feb 19, 2014
First Changed:
May 10, 2011
Disease(s):
Metabolic Syndrome
Intervention(s):
Corn and safflower oilCanola oilHigh oleic acid canola oilDHA enriched high oleic acid canola oilFlax and safflower oil
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Dec 21, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo

Connect. Empower. Inspire.